sizofiran has been researched along with Female Genital Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, Y | 1 |
| Chen, JT; Hasumi, K | 1 |
| Adachi, T; Hoshino, T; Suzuki, Y; Takayama, M; Yagishita, M | 1 |
1 review(s) available for sizofiran and Female Genital Neoplasms
| Article | Year |
|---|---|
[Phase III study of gynecologic cancer in Japan].
Topics: Adjuvants, Immunologic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Combinations; Female; Genital Neoplasms, Female; Humans; Japan; Multicenter Studies as Topic; Ovarian Neoplasms; Sizofiran; Survival Analysis; Tegafur; Uracil; Uterine Neoplasms | 2002 |
2 other study(ies) available for sizofiran and Female Genital Neoplasms
| Article | Year |
|---|---|
Activation of peritoneal macrophages in patients with gynecological malignancies by sizofiran and recombinant interferon-gamma.
Topics: Adult; Aged; Cell Count; Dinoprostone; Female; Genital Neoplasms, Female; Humans; Interferon-gamma; Interleukin-1; Macrophage Activation; Macrophages, Peritoneal; Middle Aged; Recombinant Proteins; Sizofiran; Tumor Necrosis Factor-alpha | 1993 |
[Induction of M-CSF and G-CSF receptor mRNA in peripheral blood mononuclear cells of gynecological cancer by sizofiran].
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Leukocytes, Mononuclear; Ovarian Neoplasms; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; RNA, Messenger; Sizofiran; Uterine Cervical Neoplasms | 1993 |